Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Silveray | 2026 | Series A | $5.1M | Stockport |
| twig bio | 2026 | Grant | Undisclosed | London |
| Antiverse | 2026 | Series A | $9.3M | Cardiff |
| Tropic Biosciences | 2026 | Series C | $105.0M | London |
| Nourished | 2025 | Venture - Series Unknown | $672K | Birmingham |
| Ultromics | 2025 | Series C | $55.0M | Oxford |
| Productive Machines | 2025 | Seed | $693K | Sheffield |
| Inicio AI | 2025 | Seed | $1.6M | Leicester |
| Alloyed | 2025 | Series B | $47.9M | Yarnton |
| NanoSyrinx | 2024 | Series A | $13.1M | Coventry |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 1 | Silveray | Series A | $5.1M | Stockport, United Kingdom |
| 2 | twig bio | Grant | Undisclosed | London, United Kingdom |
| 3 | Antiverse | Series A | $9.3M | Cardiff, United Kingdom |
| 4 | Tropic Biosciences | Series C | $105.0M | London, United Kingdom |
| 5 | Nourished | Venture - Series Unknown | $672K | Birmingham, United Kingdom |
| 6 | Ultromics | Series C | $55.0M | Oxford, United Kingdom |
| 7 | Productive Machines | Seed | $693K | Sheffield, United Kingdom |
| 8 | Inicio AI | Seed | $1.6M | Leicester, United Kingdom |
| 9 | Alloyed | Series B | $47.9M | Yarnton, United Kingdom |
| 10 | NanoSyrinx | Series A | $13.1M | Coventry, United Kingdom |
Silveray develop affordable large-area direct conversion detectors for the X-ray imaging market.
twig bio operates as a bioengineering startup.
Antiverse is dedicated to engineering the future of drug development to change the course of people's lives.
Tropic Biosciences is a pioneering leader in the development of novel high-performing commercial tropical crop varieties and traits.
Nourished provides a customized nutrition product that uses patented 3D printing technology to create bespoke gummy vitamins on demand.
Ultromics develops AI-driven cardiology solutions to assist in cardiovascular disease diagnosis through echocardiography.
Industry 4.0, Edge, SaaS, AI, ML, Digital Twin, Faster to the Best Part First Time
Inicio AI is a SaaS platform that builds the conversational AI driven tool that helps in income and expenditure assessment.
Alloyed develops, licenses, and manufactures proprietary alloys, alloy powders and alloy components.
NanoSyrinx is a discovery stage biotechnology company based at the University of Warwick's Medical School.
Wittaya Aqua is a farm management platform for aquaculture operations that helps farmers track, visualize and analyze production data.
OSS Is a space technology business that provides multi-award winning deployable antennas & structures made from proprietary materials.
You. Smart. Thing. is a travel demand management platform for destinations, venues, and live events.
Kubos Semiconductors is develop and commercialize cubic-GaN for high efficiency, low-cost LEDs using intellectual property.
Pencil Biosciences is a novel gene modulation company.
Eagle Genomics is a enterprise software solutions company to enable the management, orchestration and exploitation of life sciences data.
Mach42 is a University of Oxford spin-out commercializing new machine learning technology.
CHAIN Biotechnology is a microbiome therapeutics company with a novel drug development platform targeting chronic gut-related diseases.
NK:IO is a biotech company that develops novel approaches to natural killer cell-mediated immunotherapy.
Medmin is a healthcare company that offers private medical treatment for the uninsured and the clinicians that treat them.
Turning NHS Digital first strategy into reality by bringing digital innovation AI/ML
Resurrect Bio is a plant biotech company that will improve the immune system of crop species to revolutionize the agricultural industry.
XFuel produces sustainable and net-zero road, marine and aviation drop-in fuels
Nuclera offers a protein prototyping system to accelerate drug discovery by making proteins readily available to researchers.
Maeving is a new ear of beautiful, classically-styled electric motorcycles.
Future Planet Capital has invested in 102 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Future Planet Capital's top investment sectors include Biotechnology, Health Care, Artificial Intelligence (AI), Medical, Software. The firm invests across 53 different industry categories.
Among tracked funding rounds, Tropic Biosciences received $105.0M in a Series C round. Future Planet Capital's total known invested capital is $818.8M.
Future Planet Capital's average investment size is $11.1M across its portfolio of 102 companies.
Recent Future Planet Capital portfolio additions include Silveray, twig bio, Antiverse, Tropic Biosciences, Nourished. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors